AzTrials
AzTrials

Dental CavityCaries SpeciesNCT02056262

Pathogenic Species and Genotypes of Bacterial Diversity in Relation to the Severity of Dental Caries

An observational study of Dental Cavity, run by Centre Hospitalier Universitaire de Nīmes at 3 sites in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The primary objective of this study is to estimate the distribution of pathogenic species and genotypes of bacterial diversity in 7 stages ICDAS (International Caries Detection and Assessment System) corresponding to the severity of dental caries among patients aged 3-45 years consulting in the Dentistry Departments… Read more about this study

Who is it for?
Ages 3 to 45 yearsHealthy volunteers can take part
Conditions the study is for
Dental Cavity
What is being tested?
Dental cavity evaluation, Saliva sampling and Plaque sampling
How many people
56 participants
Where
3 sitesFrance
Study dates
15 Mar 2016to 8 Mar 2017
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 3 to 45 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Study population: Volunteers aged 3 to 45 who come in to the hospital for a dental consultation. Patients are recruted according to age in order to form two groups: 1/2 of participants will be between 3 and 16 years of age; the other half of participants will be between 17 and 45 years of age.

Who may be able to join

  • Volunteers aged 3 to 45 who come in to the hospital for a dental consultation
  • Minors must have parental permission
  • The patient must have given his/her informed and signed consent

Who cannot join

  • The patient is participating in another study
  • The patient is in an exclusion period determined by a previous study
  • The patient is pregnant, or breastfeeding
  • The patient has been on antibiotics within the past two months
  • Smokers
  • Teeth under current care
Show all 9Show fewer
  • Parodontopathy
  • Use of a mouthwash within the last week
  • Insufficient numbers of healthy and/or teeth with carious lesions for carrying out the study

Trial locations and contacts

3 sites in 1 country.

France3 sites
  • CHRU de Montpellier - Centre de Soins, d'Enseignement et de Recherche Dentaires

    Montpellier, 34295

  • CHRU de Montpellier - Hôpital La Colombière

    Montpellier, 34295

  • CHRU de Nîmes - Hôpital Universitaire Carémeau

    Nîmes, 30029

Other trials in France

About this study

Official title: Prevalence and Identification of Pathogenic Species and Genotypes of Bacterial Diversity in Relation to the Severity of Dental Caries

The primary objective of this study is to estimate the distribution of pathogenic species and genotypes of bacterial diversity in 7 stages ICDAS (International Caries Detection and Assessment System) corresponding to the severity of dental caries among patients aged 3-45 years consulting in the Dentistry Departments of the Nîmes University Hospital and the Montpellier University Hospital.

Read the detailed description

Secondary objectives include:

  • Compare the distribution of bacterial species in relation to stages of severity of caries
  • Compare the results from plaque with those of saliva samples.
Conditions
Dental Cavity
Being tested
Dental cavity evaluation, Saliva sampling, Plaque sampling
Keywords
Bacteria, microbial community, hygiene
Medical subject headings
Dental Caries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Dental cavity evaluationOther

    The dental cavities present will be evaluated using the ICDAS (International Caries Detection and Assessment System).

  • Saliva samplingBiological

    A saliva sample will be harvested.

  • Plaque samplingBiological

    Plaque samples from a healthy tooth and a tooth with a cavity will be harvested.

Study groups in NCT02056262
Study groupRoleWhat they receive
3 to 16 years of ageVolunteers of 3 to 16 years of age, coming in to the hospital for a dental consultation. See inclusion/exclusion criteria. Intervention: Dental cavity evaluation Intervention: Saliva sampling Intervention: Plaque sampling
Receives: Other: Dental cavity evaluation; Biological: Saliva sampling; Biological: Plaque sampling
17 - 45 years of ageVolunteers of 17 to 45 years of age, coming in to the hospital for a dental consultation. See inclusion/exclusion criteria. Intervention: Dental cavity evaluation Intervention: Saliva sampling Intervention: Plaque sampling
Receives: Other: Dental cavity evaluation; Biological: Saliva sampling; Biological: Plaque sampling

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Bacterial profile

    Bacterial profiles will be constructed using saliva and plaque samples.

    Measured: Baseline (day 0)

  2. ICDAS assessment

    Dental caries will be assessed using the ICDAS (International Caries Detection and Assessment System) system

    Measured: Baseline (day 0)

Secondary outcomes (10)
  1. Studies were stopped during high school? yes/no

    Measured: baseline (Day 0)

  2. Does the patient have at least five fillings? yes/no

    Measured: Baseline (day 0)

  3. Does the patient have at least one filling and one missing tooth on the anterior sector following the carious lesion? yes/no

    Measured: baseline (day 0)

  4. Within the last 12 months, the patient has had dental care or tooth removal following the carious lesion? yes/no

    Measured: baseline (day 0)

  5. Yesterday, did the patient eat at least three snacks (or sugary or carbonated drinks) between meals? yes/no

    Measured: Baseline (day 0)

  6. Yesterday, did the patient brush his/her teeth fewer than 2 times? yes/no

    Measured: baseline (day 0)

  7. The patient has at least one carious lesion restricted to the enamel? yes/no

    Measured: baseline (day 0)

  8. The patient has at least one carious lesion restricted to the enamel on an anterior tooth or involving the smooth surface on a posterior tooth (yes/no)

    Measured: baseline (day 0)

  9. The patient has at least one carious lesion attacking the dentin or pulp. yes/no

    Measured: baseline (day 0)

  10. The patient has at least one carious lesion reaching dentin or pulp on an anterior tooth or on the smooth surface of a posterior tooth (yes/no)

    Measured: baseline (day 0)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Feb 2014 (estimated)
  2. Study start15 Mar 2016
  3. Primary completion8 Mar 2017
  4. Study completion8 Mar 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
56 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02056262
Sponsor's protocol ID
AOI/2012/LH
Other IDs
2013-A01213-42
Acronym
Caries Species
Status last verified
Aug 2020
First submitted
4 Feb 2014
Last updated
30 Jun 2026
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Dental Cavity, run by Centre Hospitalier Universitaire de Nīmes at 3 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Bacterial profile (time frame: Baseline (day 0)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in